HSIC vs XFOR · P/E 24, rev $6.83B vs rev $4.8M
Henry Schein Inc (HSIC) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the HSIC and XFOR stock pages for the full models.
Not investment advice.